Parallel Monitoring of Plasma and Intraluminal Drug Concentrations in Man After Oral Administration of Fosamprenavir in the Fasted and Fed State

[1] Wilding I. R.(2001)The role of gamma-scintigraphy in oral drug delivery Adv. Drug Deliv. Rev. 46 103-124

[2] Coupe A. J.(2005)Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms Adv. Drug Deliv. Rev. 57 1210-1222

[3] Davis S. S.(2001)Direct estimation of the Eur. J. Pharm. Sci. 12 239-250

[4] Weitschies W.(2003) dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans Drug Metab. Dispos. 31 805-813

[5] Kosch O.(2003)Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum Br. J. Clin. Pharmacol. 55 182-190

[6] Monnikes H.(2006)The effect of ketoconazole on the Eur. J. Pharm. Sci. 29 205-214

[7] Trahms L.(2005) intestinal permeability of fexofenadine using a regional perfusion technique J. Pharm. Pharmacol. 57 987-996

[8] Bonlokke L.(2006)Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase J. Pharm. Sci. 95 372-383

[9] Hovgaard L.(2004)Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form Antimicrob. Agents Chemother. 48 791-798

[10] Kristensen H. G.(2002)Intraluminal drug and formulation behavior and integration in J. Clin. Pharmacol. 42 887-898

[1] Wilding I. R.(2001)The role of gamma-scintigraphy in oral drug delivery Adv. Drug Deliv. Rev. 46 103-124

[2] Coupe A. J.(2005)Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms Adv. Drug Deliv. Rev. 57 1210-1222

[3] Davis S. S.(2001)Direct estimation of the Eur. J. Pharm. Sci. 12 239-250

[4] Weitschies W.(2003) dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans Drug Metab. Dispos. 31 805-813

[5] Kosch O.(2003)Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum Br. J. Clin. Pharmacol. 55 182-190

[6] Monnikes H.(2006)The effect of ketoconazole on the Eur. J. Pharm. Sci. 29 205-214

[7] Trahms L.(2005) intestinal permeability of fexofenadine using a regional perfusion technique J. Pharm. Pharmacol. 57 987-996

[8] Bonlokke L.(2006)Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase J. Pharm. Sci. 95 372-383

[9] Hovgaard L.(2004)Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form Antimicrob. Agents Chemother. 48 791-798

[10] Kristensen H. G.(2002)Intraluminal drug and formulation behavior and integration in J. Clin. Pharmacol. 42 887-898